Global Breast Augmentation Market 2022-2028

September 2022 | 77 pages | ID: G7D17B16FA28EN
Gen Consulting Company

Abstracts

According to latest analysis by Gen Consulting Company, the global breast augmentation market was USD 1,085 million in 2021 and is expected to reach USD 1,558 million in 2028 and register a CAGR of 5.3% during the forecast period, 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global breast augmentation market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the breast augmentation industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, and region. The global market for breast augmentation can be segmented by product: saline implants, silicone implants. Among these, the silicone implants segment was accounted for the highest revenue generator in 2021. Breast augmentation market is further segmented by region: North America, Asia Pacific, Europe, Rest of the World (ROW). North America is estimated to account for the largest share of the global breast augmentation market.

By product:

• saline implants
• silicone implants

By region:

• North America
• Asia Pacific
• Europe
• Rest of the World (ROW)

The report has also analysed the competitive landscape of the global breast augmentation market with some of the key players being AbbVie Inc. (Allergan plc), Establishment Labs Holdings Inc., GC Aesthetics plc, Groupe Sebbin SAS, Hans Biomed Co., Ideal Implant Incorporated, Johnson & Johnson, LABORATOIRES ARION, Sientra Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global breast augmentation market.
• To classify and forecast the global breast augmentation market based on product, region.
• To identify drivers and challenges for the global breast augmentation market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global breast augmentation market.
• To identify and analyze the profile of leading players operating in the global breast augmentation market.

Why Choose This Report

• Gain a reliable outlook of the global breast augmentation market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Saline implants
Silicone implants

PART 6. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 7. KEY COMPANIES

AbbVie Inc. (Allergan plc)
Establishment Labs Holdings Inc.
GC Aesthetics plc
Groupe Sebbin SAS
Hans Biomed Co.
Ideal Implant Incorporated
Johnson & Johnson
LABORATOIRES ARION
Sientra Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER